Lawyers Lucas Maurer

Lucas Maurer

Lucas Maurer

Associate
MLaw, Attorney at Law

vCard

Location

Contact

Direct phone: +41 58 658 14 21
lucas.maurer@walderwyss.com

Curriculum Vitae

Areas of activity: Corporate / M&A Healthcare & Life Sciences Start-ups & Venture Capital

Lucas Maurer works as an Attorney at Law at Walder Wyss. He advises clients in the fields of commercial and corporate law, mergers & acquisitions, private equity, venture capital and financings.

Born in 1990, Lucas Maurer studied at the University of Basel (BLaw 2015, MLaw 2017). After completing his traineeship at a law firm in Basel, Lucas Maurer was admitted to the bar in 2019 in the canton of Basel-Stadt. He started his professional career as Legal & Compliance Counsel in the legal department of an international medical device company (2019 - 2022). During his studies he was further able to gain professional experience in the legal and in the compliance department of an international pharmaceutical company as well as in a renowned US law firm in New York.

Lucas Maurer practices in German and English. He also speaks French and has basic knowledge in Mandarin. He is registered with the Bar Register of the Canton of Basel-Stadt and is admitted to practice throughout Switzerland.

Boehringer Ingelheim acquires veterinary therapeutic vaccines developer Saiba Animal Health

10 September 2024

Flowit announced CHF 4m seed funding round

SixPeaks Bio AG debuts with USD 110 million in Funding

Walder Wyss berät P&I Personal & Informatik AG beim Verkauf der Mirus Software AG an Alpha VCX

20 December 2023

Axalta Coating Systems Group acquires André Koch AG

7 December 2023

Boehringer Ingelheim expands immuno-oncology portfolio with the acquisition of bacterial cancer therapy specialist T3 Pharma

23 November 2023

Nouscom Raises €67.5m ($72m) in Oversubscribed Series C Financing Round

15 November 2023

CONVOTIS stärkt seine Position in der Schweiz durch die neueste Akquisition der acdalis AG, einem anerkannten Spezialisten für Managed Cloud und Infrastruktur Services.

10 November 2023

Syz Capital und Saturnus Capital investieren in Capture Media

9 November 2023

Zusammenschluss von SETEX und Datatex mit Elvaston

7 November 2023

CONVOTIS startet mit der Übernahme der JMC Gruppe als Plattformunternehmen in den Schweizer IT Markt und stärkt seine Positionierung im Segment der Managed Services und digitalen Plattformlösungen.

3 November 2023

LimmaTech Biologics Raises $37 Million Series A to Advance Its Pipeline of Vaccines Against Multidrug-Resistant Bacterial Infections

15 October 2023

Pierre Fabre Laboratories acquires Vertical Bio AG

13 September 2023

Das Familienunternehmen Henke-Sass, Wolf GmbH übernimmt die Zünd Präzisionsoptik AG

Alentis Therapeutics Closes USD 105m Series C Funding

BC Platforms Announces USD 20 Million Growth Financing led by Jolt Capital

9 November 2022

Versant Ventures launches Vector BioPharma with USD 30m Series A

Engimmune Therapeutics raises CHF 15.5m in Seed Financing

Versant Ventures launches Cimeio Therapeutics with USD 50m Series A

Other lawyers

Technically necessary cookies

Essential technical cookies are necessary for the flawless functioning of our website and cannot be disabled.
Cookies for statistics

Analytical cookies enable us to count visits and traffic sources, allowing us to measure and enhance the performance of our website. They assist us in answering questions such as which pages are the most popular, which are the least used, and how visitors navigate the website. All information collected by these cookies is aggregated and therefore anonymous.
Marketing cookies may be set by our advertising partners on our website. These companies can use them to create a profile of your interests and display relevant advertisements on other websites. They operate by uniquely identifying your browser and device. By activating these cookies, you acknowledge and consent to the information collected by such cookies being sent to providers outside of Switzerland and the EU, including countries with (from the perspective of Swiss data protection law) inadequate data protection (e.g., the United States, Singapore, and Taiwan). You also acknowledge that data transmitted abroad is no longer protected by Swiss law, and foreign laws as well as regulatory orders may require the disclosure of this data to authorities and other third parties.

Marketing cookies may be set by our advertising partners on our website. These companies can use them to create a profile of your interests and display relevant advertisements on other websites. They operate by uniquely identifying your browser and device. By activating these cookies, you acknowledge and consent to the information collected by such cookies being sent to providers outside of Switzerland and the EU, including countries with (from the perspective of Swiss data protection law) inadequate data protection (e.g., the United States, Singapore, and Taiwan). You also acknowledge that data transmitted abroad is no longer protected by Swiss law, and foreign laws as well as regulatory orders may require the disclosure of this data to authorities and other third parties.